“…43,48 Because minocycline therapy has the potential for harmful adverse reactions, many authors have confirmed the need for physicians to perform pharmacovigilance, or monitoring of the safety of minocycline drug therapy regimens, to detect serious adverse effects. 4,6,15,16,19,20,25,26,31,34,38,42,[44][45][46]49,50 According to the Guide to Physical Therapist Practice, the initial examination "is a comprehensive screening and specific testing process leading to diagnostic classification, or, as appropriate, to a referral to another practitioner." 2 The inclusion of a comprehensive pharmacovigilance component in the patient examination process augments the ability of the physical therapist to identify when a referral to another practitioner is warranted.…”